Marinomed Biotech AG | WebDisclosure

PRESS RELEASE

published on 07/16/2026 at 23:10, 3 months 20 days ago

EQS-Adhoc: Ad-hoc: Marinomed Biotech AG plans to apply for court restructuring proceedings without self-administration
Marinomed Biotech AG to apply for court restructuring proceedings without self-administration due to failed negotiations and insolvency risk. Aim to secure financial stability

Marinomed Biotech AG Financial Stability Insolvency Risk Restructuring Proceedings Court-approved Restructuring Plan
BRIEF

published on 05/19/2026 at 08:03, 5 months 18 days ago

Marinomed Biotech AG Forms Strategic Partnership for Marinosolv® in Inhalation Therapy

Strategic Partnership Biopharmaceuticals Respiratory Medicine Marinosolv® Technology Inhalation Therapy
BRIEF

published on 05/19/2026 at 08:03, 5 months 18 days ago

Marinomed Biotech AG conclut un partenariat stratégique pour Marinosolv® en thérapie par inhalation

Partenariat Stratégique Produits Biopharmaceutiques Pneumologie Technologie Marinosolv® Thérapie Par Inhalation
PRESS RELEASE

published on 05/19/2026 at 07:58, 5 months 18 days ago

Marinomed Biotech AG Announces Strategic Partnership and Worldwide Licensing for Marinosolv® Technology in Inhalation Therapy
Marinomed Biotech AG partners with Phargentis SA for worldwide licensing of Marinosolv® Technology in Inhalation Therapy, offering advanced drug delivery solutions for respiratory medicine

Marinomed Biotech AG Drug Delivery Marinosolv® Technology Inhalation Therapy Phargentis SA
BRIEF

published on 05/11/2026 at 11:14, 5 months 25 days ago

Marinomed lance son collyre à base de tacrolimus sur le marché des préparations magistrales.

Marinomed Biotech AG Plateforme Marinosolv Collyre De Tacrolimus Marché À Effet Cumulatif Inflammation Oculaire
BRIEF

published on 05/11/2026 at 11:14, 5 months 25 days ago

Marinomed Advances Tacrolimus Eyedrops to Compounding Market

Marinomed Biotech AG Marinosolv Platform Tacrolimus Eyedrops Compounding Market Ocular Inflammation
PRESS RELEASE

published on 05/11/2026 at 11:09, 5 months 25 days ago

Marinomed Biotech AG announces progress with Tacrolimus Eyedrops for Entry into the Compounding Market
Marinomed Biotech AG announces progress with Tacrolimus Eyedrops for Entry into the Compounding Market, targeting niche patient populations and high-need therapeutic areas with a strategic commercial milestone

Marinomed Biotech AG Marinosolv Technology Tacrolimus Eyedrops Compounding Market Ophthalmologists
BRIEF

published on 04/22/2026 at 09:09, 6 months 13 days ago

Marinomed Biotech AG Expands into Compounding Services

Global Expansion Marinomed Biotech Marinosolv Technology Compounding Services Customized Medicines
BRIEF

published on 04/22/2026 at 09:09, 6 months 13 days ago

Marinomed Biotech AG se développe dans le domaine des services de préparation magistrale

Expansion Mondiale Technologie Marinosolv Biotechnologie Marinomed Services De Préparation Magistrale Médicaments Personnalisés
PRESS RELEASE

published on 04/22/2026 at 09:04, 6 months 13 days ago

Marinomed Announces Strategic Expansion into Compounding Services Featuring Marinosolv® Technology
Marinomed Biotech AG announces strategic expansion into compounding services with Marinosolv technology, offering personalized medicines for global demand

Marinomed Biotech AG Strategic Expansion Marinosolv Technology Compounding Services Personalized Medicines

Published on 11/06/2026 at 05:15, 3 hours 21 minutes ago

Valeo and QNX Unveil A New Smart Camera Platform at CIIE, Secures Multiple Design Wins
Published on 11/06/2026 at 01:20, 7 hours 16 minutes ago

Presentation to Munich Mining Conference
Published on 11/06/2026 at 00:53, 7 hours 43 minutes ago

Sekur Private Data Engages Darkstar Capital for Investor Awareness and Sekur Product Distribution
Published on 11/06/2026 at 00:45, 7 hours 51 minutes ago

Gabriel Announces Closure of ICSID Annulment Proceedings
Published on 11/05/2026 at 23:55, 8 hours 41 minutes ago

Santé Canada autorise deux vaccins à ARNm de Moderna : un vaccin contre la grippe et un vaccin combiné contre la grippe et la COVID-19

View all ACCESSWIRE

Published on 11/06/2026 at 08:00, 36 minutes ago

Gledhow Investments plc: Strategic Update: Originating the Next Generation of Listed Natural Resources Companies; Issue of Equity and Repayment of all outstanding Debt
Published on 11/06/2026 at 08:00, 36 minutes ago

Cairn Homes Plc: Transaction in Own Shares
Published on 11/06/2026 at 08:00, 36 minutes ago

Schweizer Electronic AG continues on its growth trajectory and achieves a turnaround in earnings in the third quarter
Published on 11/06/2026 at 07:30, 1 hour 6 minutes ago

Baader Bank launches Baader Trading Charity Weeks in support of BILD hilft e.V. „Ein Herz für Kinder“
Published on 11/06/2026 at 07:00, 1 hour 36 minutes ago

ARYZTA announces upcoming departure of its CFO

View all EQS

Published on 11/05/2026 at 18:21, 14 hours 14 minutes ago

Capital et droits de vote au 31 octobre 2026
Published on 11/05/2026 at 18:21, 14 hours 14 minutes ago

Total number of voting rights and shares making up the share capital at October 31, 2026
Published on 11/05/2026 at 18:01, 14 hours 34 minutes ago

LNA SANTE : Chiffre d'Affaires T3 2026
Published on 11/05/2026 at 17:50, 14 hours 46 minutes ago

NRJ GROUP - Financial information Q3 2026
Published on 11/05/2026 at 17:50, 14 hours 46 minutes ago

NRJ GROUP - Information financière T3 2026

View all LES ECHOS COMFI WIRE

News